SyntheX

'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal
Fierce Biotech
Tue, 10/4/22 - 11:04 am
Bristol Myers Squibb
SyntheX
molecular glue
molecular degraders
biobucks